Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Marchiafava-Bignami syndrome]

Y Narita

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |January 1, 1977
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective, multicenter, observational study of trastuzumab deruxtecan in elderly patients with HER2-positive gastric cancer: EN-COURAGE.

    ESMO gastrointestinal oncology·2026
    Same author

    Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer.

    Breast cancer (Tokyo, Japan)·2026
    Same author

    Readministration of nivolumab for patients with advanced gastric cancer: a case series.

    ESMO gastrointestinal oncology·2026
    Same author

    Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study.

    ESMO gastrointestinal oncology·2026
    Same author

    Practical management of oligometastatic gastric cancer.

    ESMO gastrointestinal oncology·2026
    Same author

    WJOG18524G: a single-arm phase II study evaluating bemarituzumab combined with ramucirumab and paclitaxel in fibroblast growth factor receptor 2b (FGFR2b)-positive advanced gastric or gastroesophageal junction cancer (RAINBIRD).

    ESMO gastrointestinal oncology·2026
    Same journal

    [Development of novel therapeutics for multiple myeloma and improvement of drug lag].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Clinical pharmacy services to patients of immunomodulatory drugs].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    See all related articles